Reabilitação vocal de laringectomizados com prótese traqueoesofágica Vocal reabilitation of patients with laringectomy using tracheoesofogeal proteses

Material: No período de 23 de fevereiro de 1999 a junho de 2000 foram estudados 23 pacientes submetidos à laringectomia total que receberam a prótese traqueoesofágica do tipo Blom-Singer Indeweling Low Presure, sendo 22 pacientes do sexo masculino, com faixa etária variando de 40 a 80 anos. O tempo de acompanhamento variou de 150 a 462 dias. Um paciente era do estádio clínico I, com comprometimento da comissura posterior; um, do estádio II, com lesão na subglote; 13, do estádio III; e sete do IV. Forma de estudo: Prospectivo clínico não randomizado. Método: A prótese foi locada concomitante à laringectomia em sete pacientes; secundariamente, com anestesia geral, em cinco; e, por endoscopia digestiva alta, sob sedação e anestesia local, em quatorze. Foram estudadas as complicações decorrentes da colocação e uso da prótese vocal, avaliação da qualidade da voz e da inteligibilidade de fala, utilizando parâmetro perceptivo-auditivo, antes e depois da fonoterapia e do tempo necessário para reabilitação vocal. Resultados: Houve três complicações pós-operatórias relacionadas com procedimento cirúrgico terapêutico, que impossibilitaram a reabilitação vocal; dos vinte possíveis de serem reabilitados com a prótese, dezoito se reabilitaram com índice de 90% de sucesso. O tempo médio para reabilitação variou de um a 65 dias. Conclusão: Concluímos que as complicações decorrentes da colocação e uso da prótese não inviabilizaram o sucesso do método; o tempo médio para aquisição da voz foi de sete dias; a qualidade vocal e a inteligibilidade de fala apresentaram melhora após a realização da fonoterapia, sem diferença estatística significativa; e a colocação secundária da prótese vocal, utilizando nova técnica, por endoscopia digestiva alta, mostrou-se mais eficaz em relação às técnicas convencionais.<br>We studied the complications resulting from the placement and use of the vocal prosthesis, assessment of voice quality and speech intelligibility using perceptive-auditory parameters before and after speech therapy and the period needed for vocal rehabilitation. From February 1999 to June 2000, a study was conducted on 23 patients who underwent total laryngectomy and were given a tracheoesophageal prosthesis like the Blom-Singer Indwelling Low Pressure. Study design: Prospective clinical not randomized. Material and method: The study consisted of 22 males and their ages ranged from 40 years to 80 years. The follow up period varied between 150 days to 462 days. One patient with the posterior commissure affected was at stadium I; stadium II had one patient with a lesion in the subglottic region; stadium III had 13 patients; stadium IV had four patients. The prosthesis was placed in seven patients concomitantly with the laryngectomy, while the placement was secondary in the remaining group. Aim: We studied the complications resulting from the placement and use of the vocal prosthesis, assessment of voice quality and speech intelligibility using perceptive-auditory parameters before and after speech therapy and the period needed for vocal rehabilitation impossible. The success rating was 90% with 18 patients rehabilitated with the help of the prosthesis. The rehabilitation period varied between one day to 65 days. Conclusions: the complications resulted from placement and use of this prosthesis did not hamper its success; the average time taken for voice acquisition was seven days, vocal quality and intelligibility of speech showed improvement after the phonoterapy without significant statistics difference and the secondary placement through new surgical technique by digestive endoscopy is better than the conventional technique

Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinoma

Global DNA hypomethylation has been associated with increased risk for cancers of the colorectum, bladder, breast, head and neck, and testicular germ cells. The aim of this study was to examine whether global hypomethylation in blood leukocyte DNA is associated with the risk of hepatocellular carcinoma (HCC). A total of 315 HCC cases and 356 age-, sex- and HBsAg status-matched controls were included. Global methylation in blood leukocyte DNA was estimated by analyzing long interspersed element-1 (LINE-1) repeats using bisulfite-polymerase chain reaction (PCR) and pyrosequencing. We observed that the median methylation level in HCC cases (percentage of 5-methylcytosine (5mC)=77.7%) was significantly lower than that in controls (79.5% 5mC) (P=0.004, Wilcoxon rank-sum test). The odds ratios (ORs) of HCC for individuals in the third, second, and first (lowest) quartiles of LINE-1 methylation were 1.1 (95% confidence interval (CI) 0.7–1.8), 1.4 (95% CI 0.8–2.2), and 2.6 (95% CI 1.7–4.1) (P for trend <0.001), respectively, compared to individuals in the fourth (highest) quartile. A 1.9-fold (95% CI 1.4–2.6) increased risk of HCC was observed among individuals with LINE-1 methylation below the median compared to individuals with higher (>median) LINE-1 methylation. Our results demonstrate for the first time that individuals with global hypomethylation measured in LINE-1 repeats in blood leukocyte DNA have an increased risk for HCC. Our data provide the evidence that global hypomethylation detected in the easily obtainable DNA source of blood leukocytes may help identify individuals at risk of HCC